Robert C. Kane
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 2%
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Hematology 11
- Multiple Myeloma Research and Treatments 5
- Chronic Myeloid Leukemia Treatments 4
- Oncology 11
- Cancer Treatment and Pharmacology 3
- CAR-T cell therapy research 2
- Co-authors
- Richard M. Pazdur (15 shared papers)Ann T. Farrell (13 shared papers)Rajeshwari Sridhara (6 shared papers)Robert L. Justice (9 shared papers)Peter F. Bross (1 shared paper)Chia‐Wen Ko (4 shared papers)Haleh Saber (5 shared papers)Ramzi N. Dagher (2 shared papers)
- Journals
- Clinical Cancer Research (11 papers)The Oncologist (6 papers)JAMA (3 papers)Blood (2 papers)Journal of Oncology Practice (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Robert C. Kane
44 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 138
- Hematology 753
- Oncology 1.4k
- Genetics 446
- Molecular Biology 1.9k
- Pathology and Forensic Medicine 448
Countries citing papers authored by Robert C. Kane
This map shows the geographic impact of Robert C. Kane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Kane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Kane more than expected).
Fields of papers citing papers by Robert C. Kane
This network shows the impact of papers produced by Robert C. Kane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Kane. The network helps show where Robert C. Kane may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert C. Kane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 537 | |
| 2 | 2006 | 414 | |
| 3 | 2015 | 306 | |
| 4 | 2015 | 301 | |
| 5 | 2004 | 300 | |
| 6 | 2006 | 297 | |
| 7 | 2007 | 296 | |
| 8 | 2013 | 209 | |
| 9 | 2009 | 196 | |
| 10 | 2017 | 187 | |
| 11 | 2012 | 186 | |
| 12 | 2015 | 173 | |
| 13 | 2015 | 140 | |
| 14 | 2015 | 131 | |
| 15 | 2013 | 85 | |
| 16 | 1979 | 81 | |
| 17 | 2008 | 64 | |
| 18 | 1977 | 52 | |
| 19 | Adriamycin therapy in American patients with hepatocellular carcinoma. | 1977 | 51 |
| 20 | 1976 | 48 |
About Robert C. Kane
Robert C. Kane is a scholar working on Hematology, Oncology, Genetics, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 4.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Multiple Myeloma Research and Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Protein Degradation and Inhibitors (3 papers), Cancer Treatment and Pharmacology (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Hematology (753 citations), Oncology (1.4k citations), Genetics (446 citations), Molecular Biology (1.9k citations) and Pathology and Forensic Medicine (448 citations). Robert C. Kane has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Richard M. Pazdur, Ann T. Farrell, Rajeshwari Sridhara, Robert L. Justice, Peter F. Bross, Chia‐Wen Ko, Haleh Saber, Ramzi N. Dagher, Brian P. Booth and Edvardas Kaminskas. Their work appears in journals such as Clinical Cancer Research, The Oncologist, JAMA, Blood and Journal of Oncology Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.